These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34763675)

  • 1. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis.
    Schäffer AA; Dominguez DA; Chapman LM; Gertz EM; Budhu A; Forgues M; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Wu X; Bayarsaikhan E; Harris CC; Ruchirawat M; Ruppin E; Wang XW
    BMC Genomics; 2021 Nov; 22(1):814. PubMed ID: 34763675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas.
    An J; Kim D; Oh B; Oh YJ; Song J; Park N; Kim HI; Kang HJ; Oh JH; Kim W; Lee E; Sung CO; Song GW; Kim DG; Yu E; Letouzé E; Zucman-Rossi J; Lee HC; Shim JH
    Hepatology; 2022 Apr; 75(4):997-1011. PubMed ID: 34478159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.
    Zhao L; Wang Y; Tian T; Rao X; Dong W; Zhang J; Yang Y; Tao Q; Peng F; Shen C; Wang S; Liu H; Zeng X; Zhou W
    Hepatol Int; 2022 Dec; 16(6):1339-1352. PubMed ID: 36123506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus in the liver: natural history and consequences in tumour development.
    La Bella T; Imbeaud S; Peneau C; Mami I; Datta S; Bayard Q; Caruso S; Hirsch TZ; Calderaro J; Morcrette G; Guettier C; Paradis V; Amaddeo G; Laurent A; Possenti L; Chiche L; Bioulac-Sage P; Blanc JF; Letouze E; Nault JC; Zucman-Rossi J
    Gut; 2020 Apr; 69(4):737-747. PubMed ID: 31375600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma.
    Péneau C; Imbeaud S; La Bella T; Hirsch TZ; Caruso S; Calderaro J; Paradis V; Blanc JF; Letouzé E; Nault JC; Amaddeo G; Zucman-Rossi J
    Gut; 2022 Mar; 71(3):616-626. PubMed ID: 33563643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
    Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
    Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
    Wang C; Chen C; Hu W; Tao L; Chen J
    Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Sripan D; Chornkrathok C; Budhu A; Budhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Ungtrakul T; Sricharunrat T; Phornphutkul K; Sangrajang S; Loffredo CA; Harris CC; Mahidol C; Wang XW; Ruchirawat M;
    Sci Rep; 2023 Jul; 13(1):11406. PubMed ID: 37452065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
    Lee WY; Bachtiar M; Choo CCS; Lee CG
    Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
    Mathkar PP; Chen X; Sulovari A; Li D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral integration drives multifocal HCC during the occult HBV infection.
    Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
    Ramirez R; van Buuren N; Gamelin L; Soulette C; May L; Han D; Yu M; Choy R; Cheng G; Bhardwaj N; Chiu J; Muench RC; Delaney WE; Mo H; Feierbach B; Li L
    J Virol; 2021 Sep; 95(19):e0029921. PubMed ID: 34287049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
    Qian Z; Liang J; Huang R; Song W; Ying J; Bi X; Zhao J; Shi Z; Liu W; Liu J; Li Z; Zhou J; Huang Z; Zhang Y; Zhao D; Wu J; Wang L; Chen X; Mao R; Zhou Y; Guo L; Hu H; Ge D; Li X; Luo Z; Yao J; Li T; Chen Q; Wang B; Wei Z; Chen K; Qu C; Cai J; Jiao Y; Bao L; Zhao H
    Gut; 2024 Jun; 73(7):1169-1182. PubMed ID: 38395437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.
    Yeh SH; Li CL; Lin YY; Ho MC; Wang YC; Tseng ST; Chen PJ
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):921-929. PubMed ID: 36690297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV Infection: Protection from Cancer.
    Srivastava A; Carter BJ
    Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma.
    Ren H; Chen X; Wang J; Chen Y; Hafiz A; Xiao Q; Fu S; Madireddy A; Li WV; Shi X; Cao J
    J Med Virol; 2023 Oct; 95(10):e29187. PubMed ID: 37877809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.
    Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D
    Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
    D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
    J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.